Luckily, 2025 has given werewolf enthusiasts one of the best stories focusing on the supernatural beasts in recent memory, ...

As of Wednesday, December 17, Werewolf Therapeutics, Inc.’s HOWL share price has surged by 8.80%, which has investors questioning if this is right time to sell.

Matthew Galea is a features writer for CBR. He spends his day as a high school English teacher, and every other minute watching, thinking and writing about movies and television. From Lon Chaney Jr.'s ...

There’s a saying (or at least a sentiment) among horror geeks: Werewolves always get short shrift. They just do. Of the classic cinematic monsters, which were essentially canonized in the public ...